Gene therapy for chronic relapsing experimental allergic encephalomyelitis using cells expressing a novel soluble p75 dimeric TNF receptor.

In a murine relapsing experimental allergic encephalomyelitis (EAE) model, gene therapy to block TNF was investigated with the use of a retroviral dimeric p75 TNF receptor (dTNFR) construct. To effectively produce these TNF inhibitors in vivo, a conditionally immortalized syngeneic fibroblast line w...

Full description

Bibliographic Details
Main Authors: Croxford, J, Triantaphyllopoulos, K, Neve, R, Feldmann, M, Chernajovsky, Y, Baker, D
Format: Journal article
Language:English
Published: 2000